Guardian Pharmacy Services, Inc.
GRDN- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001802255
No open-market purchases or sales by Guardian Pharmacy Services, Inc. insiders were filed in the last 90 days; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Guardian Pharmacy Services, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Guardian Pharmacy Services, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mudd William Franklin | See Remarks | 136,747 | Sep 28, 2026 | 1 |
| Weir Robert | See Remarks | 103,333 | Sep 28, 2026 | 1 |
| Ackerman John | Director, Other: Member of 10% Owner Group | 1,287,237Indirect | Sep 28, 2026 | 3 |
| Salentine Thomas J Jr | Director, 10% Owner, Other: Member of 10% Owner Group | 16,669,666Indirect | Sep 28, 2026 | 3 |
| Martin David Norman | See Remarks | 140,905 | Sep 28, 2026 | 1 |
| Pharmacy Investors, LLC | Other: Member of 10% Owner Group | 3,863,806 | Sep 28, 2026 | 3 |
| Burke Fred | See Remarks | 3,438,064 | Sep 28, 2026 | 5 |
| Tuch Jeffrey | See Remarks | 231,847 | Sep 28, 2026 | 1 |
| Forbes Kendall | Other: Member of 10% Owner Group | 1,651,059 | Sep 28, 2026 | 6 |
| Bindley William E | Director, 10% Owner, Other: Member of 10% Owner Group | 16,669,666Indirect | Sep 28, 2026 | 3 |
| Morris David K | See Remarks | 896,341 | Sep 28, 2026 | 5 |
| Crisafulli Chris | See Remarks | 53,057 | Sep 28, 2026 | 1 |
| Eakins Richard | Senior Vice President, Sales | 134,930 | Sep 28, 2026 | 1 |
| Cardinal Equity Fund, L.P. | Other: Member of 10% owner Group | 1,287,237 | Sep 28, 2026 | 3 |
| Bindley Capital Partners I, LLC | 10% Owner, Other: Member of 10% Owner Group | 16,669,666 | Sep 28, 2026 | 3 |
| Towns Douglas | See Remarks | 113,006 | Sep 28, 2026 | 1 |
| Lewis Randall J | Director | 15,071 | May 7, 2026 | 1 |
| Cosler Steven D | Director | 29,012 | May 7, 2026 | 2 |
| Patchett Mary Sue | Director | 15,071 | May 7, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Morris David KSee Remarks | SSaleClass A Common Stock | −187.9K | $29.68 | −$5.58M | −42.5%254.5K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Pharmacy Investors, LLCOther: Member of 10% owner group | SSaleClass A Common Stock | −827.6K | $29.68 | −$24.6M | −44.4%1.04M after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Burke FredSee Remarks | SSaleClass A Common Stock | −671.4K | $29.68 | −$19.9M | −44.4%840.4K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Salentine Thomas J JrDirector, 10% Owner | SSaleClass A Common Stock | −3.57M | $29.68 | −$106.0M | −44.4%4.47M after | Duplicate filing |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Bindley Capital Partners I, LLC10% Owner | SSaleClass A Common Stock | −3.57M | $29.68 | −$106.0M | −44.4%4.47M after | Duplicate filing |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Ackerman JohnDirector | SSaleClass A Common Stock | −1.10M | $29.68 | −$32.7M | −76.2%345.1K after | 2 lots |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Bindley William EDirector, 10% Owner | SSaleClass A Common Stock | −3.57M | $29.68 | −$106.0M | −44.4%4.47M after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Forbes KendallSee Remarks | SSaleClass A Common Stock | −346.7K | $29.68 | −$10.3M | −43.3%453.3K after | |
| Mar 24, 2026 (view filing) | Mar 20 | 4 days | Cardinal Equity Fund, L.P.Other: Member of 10% owner group | SSaleClass A Common Stock | −275.7K | $29.68 | −$8.18M | −44.4%345.1K after | |
| Dec 5, 2025 (view filing) | Dec 3 | 2 days | Cosler Steven DDirector | PPurchaseClass A Common Stock | +3.37K | $29.61 | +$99.8K | +15.6%25.0K after | |
| Sep 30, 2025 (view filing) | May 27-28 | 126 daysLate | Cardinal Equity Fund, L.P.Other: Member of 10% owner group | SSaleClass A Common Stock | −321.3K | $20.16 | −$6.48M | −68.2%149.8K after | 2 lots |
| Sep 30, 2025 (view filing) | May 27-28 | 126 daysLate | Pharmacy Investors, LLCOther: Member of 10% owner group | SSaleClass A Common Stock | −964.3K | $20.16 | −$19.4M | −68.2%449.6K after | 2 lots |
| May 29, 2025 (view filing) | May 27-28 | 2 days | Bindley William EDirector, 10% Owner | SSaleClass A Common Stock | −4.16M | $20.16 | −$83.9M | −68.2%1.94M after | 2 lotsDuplicate filing |
| May 29, 2025 (view filing) | May 27-28 | 2 days | Salentine Thomas J JrDirector, 10% Owner | SSaleClass A Common Stock | −4.16M | $20.16 | −$83.9M | −68.2%1.94M after | 2 lotsDuplicate filing |
| May 29, 2025 (view filing) | May 27-28 | 2 days | Ackerman JohnDirector | SSaleClass A Common Stock | −1.29M | $20.16 | −$25.9M | −89.6%149.8K after | 4 lots |
| May 29, 2025 (view filing) | May 27-28 | 2 days | Morris David KSee Remarks | SSaleClass A Common Stock | −437.8K | $20.16 | −$8.83M | −67.1%214.5K after | 2 lots |
| May 29, 2025 (view filing) | May 27-28 | 2 days | Burke FredSee Remarks | SSaleClass A Common Stock | −885.8K | $20.16 | −$17.9M | −68.2%413.0K after | 2 lots |
| May 29, 2025 (view filing) | May 27-28 | 2 days | Forbes KendallSee Remarks | SSaleClass A Common Stock | −415.0K | $20.16 | −$8.37M | −67.1%203.9K after | 2 lots |
| May 29, 2025 (view filing) | May 27-28 | 2 days | Bindley Capital Partners I, LLC10% Owner | SSaleClass A Common Stock | −4.16M | $20.16 | −$83.9M | −68.2%1.94M after | 2 lots |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | Cosler Steven DDirector | PPurchaseClass A Common Stock | +7.00K | $21.22 | +$148.5K | +65.3%17.7K after | |
| Oct 1, 2024 (view filing) | Sep 27 | 4 days | Salentine Thomas J JrDirector | PPurchaseClass A Common Stock | +35.7K | $14.00 | +$500.0K | New position35.7K after | |
| Oct 1, 2024 (view filing) | Sep 27 | 4 days | Patchett Mary SueDirector | PPurchaseClass A Common Stock | +3.57K | $14.00 | +$50.0K | New position3.57K after | |
| Oct 1, 2024 (view filing) | Sep 27 | 4 days | Lewis Randall JDirector | PPurchaseClass A Common Stock | +3.57K | $14.00 | +$50.0K | New position3.57K after | |
| Oct 1, 2024 (view filing) | Sep 27 | 4 days | Cosler Steven DDirector | PPurchaseClass A Common Stock | +7.14K | $14.00 | +$100.0K | New position7.14K after |